Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
Ipamorelin and BAC Water Mix

Ipamorelin Reconstitution Calculator

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example Ipamorelin Titration Schedule

ItemDetails
Dose100–300 mcg per injection
Frequency2–3× per day (1–7×/week understates)
Cycle8–12 weeks on / 4–8 off
SelectivityNo appetite/cortisol/prolactin effect

The most selective GHRP (Raun 1998). Its Phase 2 trial in postoperative ileus failed the primary endpoint (p=0.15) and FDA's advisory committee voted 12-0 against compounding eligibility in October 2024. Frequency should read per-day, not per-week.

Possible vial strengths:

What Is It?

Ipamorelin

Selective ghrelin receptor agonist, mild GH pulse.

Bacteriostatic Water

Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.

How To Mix Ipamorelin

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw BAC Water

Draw the selected amount of bacteriostatic water.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

Ipamorelin Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

Ipamorelin is a synthetic pentapeptide that works as a selective growth hormone secretagogue, binding the ghrelin receptor (GHS-R1a) in the pituitary to trigger short, natural-style pulses of growth hormone. It was originally developed by Novo Nordisk and is one of the most receptor-selective GHRPs, which is why it circulates as a research peptide rather than an approved medicine. It contains no growth hormone itself — it prompts your own pituitary to release more.
In research and clinical write-ups, ipamorelin is discussed in micrograms — commonly around 100–300 mcg per dose, subcutaneously, once or up to a few times a day. Because its half-life is only about 2 hours, doses are usually timed to an empty stomach and often before bed, when natural GH release peaks. These figures are not an approved schedule; the right amount, frequency, and whether it's appropriate at all are clinical decisions.
Add bacteriostatic water to the dry vial and let it dissolve without shaking. For example, a 5 mg vial + 2 mL of water gives 2.5 mg/mL (2,500 mcg/mL); a 250 mcg dose is then 0.1 mL, which is 10 units on a U-100 insulin syringe. Adjust the math to your vial's actual strength — the calculator above handles any vial size and target dose. Working in micrograms matters here, since ipamorelin doses are far smaller than the milligram doses used for GLP-1 peptides.
Ipamorelin's defining trait is selectivity: unlike older secretagogues such as GHRP-6, it raises growth hormone with little effect on cortisol, prolactin, or strong hunger signaling, so appetite spikes tend to be mild or absent. It does not directly raise testosterone — it acts on the GH/IGF-1 axis, not the reproductive hormone axis. This "clean" profile is exactly why it's the ghrelin-receptor half so often paired with a separate GHRH-type peptide that works through a different receptor; how any such pairing is dosed is a clinical decision, not something to merge on a calculator.
Despite ipamorelin's online reputation as the "safest" or "cleanest" peptide, that reputation rests mostly on short Phase II trials and anecdote — it has never been approved by the FDA or any major regulator and has limited long-term human safety data. Reported effects include injection-site reactions, headache, and water retention, and any sustained rise in GH/IGF-1 can affect blood sugar and insulin sensitivity, so it is not risk-free. Store lyophilized vials refrigerated and out of light; once reconstituted, keep them cold and use within a few weeks. Selectivity reduces certain side effects — it does not make an unapproved compound proven-safe.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

About the author

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides